RecruitingPulmonary Hypertension
Real World Observational Study of Sotatercept for Pulmonary Hypertension
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this study seeks to describe the real world initial experience with sotatercept in the treatment of pulmonary hypertension.
Sponsor: Mayo Clinic
You may qualify if…
- ✓ Adults age 18 or greater who are being treated with sotatercept in the Mayo Pulmonary hypertension clinic.
You may not qualify if…
- ✕ Adults lacking capacity to consent
Where it's recruiting
Minnesota
Rochester
Source: ClinicalTrials.gov · NCT06751082 · last updated 2026-04-06